Copyright Reports & Markets. All rights reserved.

Global EGFR Mutation Test Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 EGFR Mutation Test Market Overview

      • 1.1 Product Overview and Scope of EGFR Mutation Test
      • 1.2 EGFR Mutation Test Segment by Type
        • 1.2.1 Global EGFR Mutation Test Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 DNA Sequencing
        • 1.2.3 Kits
      • 1.3 EGFR Mutation Test Segment by Application
        • 1.3.1 EGFR Mutation Test Consumption Comparison by Application (2014-2025)
        • 1.3.2 Cancer Hospitals
        • 1.3.3 Clinical Research Institutes
      • 1.4 Global EGFR Mutation Test Market by Region
        • 1.4.1 Global EGFR Mutation Test Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global EGFR Mutation Test Market Size
        • 1.5.1 Global EGFR Mutation Test Revenue (2014-2025)
        • 1.5.2 Global EGFR Mutation Test Production (2014-2025)

      2 Global EGFR Mutation Test Market Competition by Manufacturers

      • 2.1 Global EGFR Mutation Test Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global EGFR Mutation Test Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global EGFR Mutation Test Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers EGFR Mutation Test Production Sites, Area Served, Product Types
      • 2.5 EGFR Mutation Test Market Competitive Situation and Trends
        • 2.5.1 EGFR Mutation Test Market Concentration Rate
        • 2.5.2 EGFR Mutation Test Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global EGFR Mutation Test Production Market Share by Regions

      • 3.1 Global EGFR Mutation Test Production Market Share by Regions
      • 3.2 Global EGFR Mutation Test Revenue Market Share by Regions (2014-2019)
      • 3.3 Global EGFR Mutation Test Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America EGFR Mutation Test Production
        • 3.4.1 North America EGFR Mutation Test Production Growth Rate (2014-2019)
        • 3.4.2 North America EGFR Mutation Test Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe EGFR Mutation Test Production
        • 3.5.1 Europe EGFR Mutation Test Production Growth Rate (2014-2019)
        • 3.5.2 Europe EGFR Mutation Test Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China EGFR Mutation Test Production (2014-2019)
        • 3.6.1 China EGFR Mutation Test Production Growth Rate (2014-2019)
        • 3.6.2 China EGFR Mutation Test Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan EGFR Mutation Test Production (2014-2019)
        • 3.7.1 Japan EGFR Mutation Test Production Growth Rate (2014-2019)
        • 3.7.2 Japan EGFR Mutation Test Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global EGFR Mutation Test Consumption by Regions

      • 4.1 Global EGFR Mutation Test Consumption by Regions
      • 4.2 North America EGFR Mutation Test Consumption (2014-2019)
      • 4.3 Europe EGFR Mutation Test Consumption (2014-2019)
      • 4.4 China EGFR Mutation Test Consumption (2014-2019)
      • 4.5 Japan EGFR Mutation Test Consumption (2014-2019)

      5 Global EGFR Mutation Test Production, Revenue, Price Trend by Type

      • 5.1 Global EGFR Mutation Test Production Market Share by Type (2014-2019)
      • 5.2 Global EGFR Mutation Test Revenue Market Share by Type (2014-2019)
      • 5.3 Global EGFR Mutation Test Price by Type (2014-2019)
      • 5.4 Global EGFR Mutation Test Production Growth by Type (2014-2019)

      6 Global EGFR Mutation Test Market Analysis by Applications

      • 6.1 Global EGFR Mutation Test Consumption Market Share by Application (2014-2019)
      • 6.2 Global EGFR Mutation Test Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in EGFR Mutation Test Business

      • 7.1 Abbott
        • 7.1.1 Abbott EGFR Mutation Test Production Sites and Area Served
        • 7.1.2 EGFR Mutation Test Product Introduction, Application and Specification
        • 7.1.3 Abbott EGFR Mutation Test Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Merck
        • 7.2.1 Merck EGFR Mutation Test Production Sites and Area Served
        • 7.2.2 EGFR Mutation Test Product Introduction, Application and Specification
        • 7.2.3 Merck EGFR Mutation Test Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Thermo Fisher Scientific
        • 7.3.1 Thermo Fisher Scientific EGFR Mutation Test Production Sites and Area Served
        • 7.3.2 EGFR Mutation Test Product Introduction, Application and Specification
        • 7.3.3 Thermo Fisher Scientific EGFR Mutation Test Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Illumina
        • 7.4.1 Illumina EGFR Mutation Test Production Sites and Area Served
        • 7.4.2 EGFR Mutation Test Product Introduction, Application and Specification
        • 7.4.3 Illumina EGFR Mutation Test Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 BioMerieux
        • 7.5.1 BioMerieux EGFR Mutation Test Production Sites and Area Served
        • 7.5.2 EGFR Mutation Test Product Introduction, Application and Specification
        • 7.5.3 BioMerieux EGFR Mutation Test Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 QIAGEN
        • 7.6.1 QIAGEN EGFR Mutation Test Production Sites and Area Served
        • 7.6.2 EGFR Mutation Test Product Introduction, Application and Specification
        • 7.6.3 QIAGEN EGFR Mutation Test Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Agilent Technologies
        • 7.7.1 Agilent Technologies EGFR Mutation Test Production Sites and Area Served
        • 7.7.2 EGFR Mutation Test Product Introduction, Application and Specification
        • 7.7.3 Agilent Technologies EGFR Mutation Test Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Hologic
        • 7.8.1 Hologic EGFR Mutation Test Production Sites and Area Served
        • 7.8.2 EGFR Mutation Test Product Introduction, Application and Specification
        • 7.8.3 Hologic EGFR Mutation Test Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Novartis
        • 7.9.1 Novartis EGFR Mutation Test Production Sites and Area Served
        • 7.9.2 EGFR Mutation Test Product Introduction, Application and Specification
        • 7.9.3 Novartis EGFR Mutation Test Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Roche
        • 7.10.1 Roche EGFR Mutation Test Production Sites and Area Served
        • 7.10.2 EGFR Mutation Test Product Introduction, Application and Specification
        • 7.10.3 Roche EGFR Mutation Test Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Genomic Health

      8 EGFR Mutation Test Manufacturing Cost Analysis

      • 8.1 EGFR Mutation Test Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of EGFR Mutation Test
      • 8.4 EGFR Mutation Test Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 EGFR Mutation Test Distributors List
      • 9.3 EGFR Mutation Test Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global EGFR Mutation Test Market Forecast

      • 11.1 Global EGFR Mutation Test Production, Revenue Forecast
        • 11.1.1 Global EGFR Mutation Test Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global EGFR Mutation Test Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global EGFR Mutation Test Price and Trend Forecast (2019-2025)
      • 11.2 Global EGFR Mutation Test Production Forecast by Regions (2019-2025)
        • 11.2.1 North America EGFR Mutation Test Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe EGFR Mutation Test Production, Revenue Forecast (2019-2025)
        • 11.2.3 China EGFR Mutation Test Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan EGFR Mutation Test Production, Revenue Forecast (2019-2025)
      • 11.3 Global EGFR Mutation Test Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America EGFR Mutation Test Consumption Forecast (2019-2025)
        • 11.3.2 Europe EGFR Mutation Test Consumption Forecast (2019-2025)
        • 11.3.3 China EGFR Mutation Test Consumption Forecast (2019-2025)
        • 11.3.4 Japan EGFR Mutation Test Consumption Forecast (2019-2025)
      • 11.4 Global EGFR Mutation Test Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global EGFR Mutation Test Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Epidermal growth factor receptor (EGFR) is a type of protein, which is located on the surface of human body cells. Any mutation in EGFR gene can lead to various types of cancer. EGFR functions as a biomarker for non-small cell lung cancer (NSCLC) and due to the mutation of EGFR gene a person may suffer from cancer or may have a tumor growth. Tumors with genetically altered EGFR gene are referred to as EGFR-mutated tumors. EGFR mutation is generally observed in NSCLCs, especially in adenocarcinoma tumors. According to the International Association for the Study of Lung Cancer, American Thoracic Society and European Respiratory Society, there are around 50% of surgically resected lung adenocarcinomas in EGFR mutations. These mutations are related to micro papillary predominant subtype and the bronchioloalveolar carcinoma. EGFR biomarker is used in diagnosis of patients with NSCLC. Targeted therapy involving tyrosine kinase inhibitors such as gefitinib and erotinib is used in the treatment of patients with NSCLC. EGFR biomarker detects the presence of specific alterations in EGFR gene, which may lead to the development of tumor.   
        Increasing global prevalence of lung cancer is expected to fuel growth of the global EGFR mutation test market over the forecast period. Increasing adoption of biomarker therapy is also expected to boost growth of the market worldwide over the forecast period.

        The global EGFR Mutation Test market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on EGFR Mutation Test volume and value at global level, regional level and company level. From a global perspective, this report represents overall EGFR Mutation Test market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Abbott
        Merck
        Thermo Fisher Scientific
        Illumina
        BioMerieux
        QIAGEN
        Agilent Technologies
        Hologic
        Novartis
        Roche
        Genomic Health

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        DNA Sequencing
        Kits

        Segment by Application
        Cancer Hospitals
        Clinical Research Institutes

        Buy now